[{"address1": "830 Winter Street", "city": "Waltham", "state": "MA", "zip": "02451", "country": "United States", "phone": "857 399 9500", "website": "https://www.tscan.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "TScan Therapeutics, Inc., a clinical-stage biotechnology company, develops T cell receptor-engineered T cell (TCR-T) therapies for the treatment of patients with cancer in the United States. The company's lead product candidates include TSC-100 and TSC-101 for the treatment of patients with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and acute lymphoblastic leukemia (ALL) in patients undergoing allogeneic hematopoietic cell transplantation (HCT) is in Phase I clinical trial, as well as eliminates residual disease and promotes donor chimerism. It also advanced TS-102 into IND-enabling activities. In addition, the company develops TSC-200, TSC-201, TSC-202, TSC-203, and TSC-204, which are in Phase 1 clinical trial, for the treatment of solid tumors. It has collaboration agreements with Novartis Institutes for BioMedical Research, Inc. to discover and develop novel TCR-T therapies; and Amgen Inc. to identify antigens recognized by T cells in patients with Crohn's disease using TargetScan, a proprietary target discovery platform. TScan Therapeutics, Inc. was incorporated in 2018 and is headquartered in Waltham, Massachusetts.", "fullTimeEmployees": 146, "companyOfficers": [{"maxAge": 1, "name": "Dr. Gavin  MacBeath Ph.D.", "age": 55, "title": "CEO & Director", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 1025727, "exercisedValue": 0, "unexercisedValue": 207573}, {"maxAge": 1, "name": "Mr. Jason A. Amello CPA", "age": 57, "title": "CFO & Treasurer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 767342, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Chrystal U. Louis M.D., M.P.H.", "age": 49, "title": "Chief Medical Officer", "yearBorn": 1976, "fiscalYear": 2024, "totalPay": 550125, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stephen J. Elledge Ph.D.", "title": "Co-Founder & Chairman of Scientific Advisory Board", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Tomasz  Kula Ph.D.", "title": "Co-Founder & Member of Advisory Board", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Leiden  Dworak M.B.A.", "age": 41, "title": "Principal Accounting Officer", "yearBorn": 1984, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Zoran  Zdraveski J.D., Ph.D.", "age": 55, "title": "Chief Legal & Strategy Officer and Company Secretary", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 657200, "exercisedValue": 0, "unexercisedValue": 85247}, {"maxAge": 1, "name": "Ms. Ann  Hargraves", "title": "Senior Vice President of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Shrikanta  Chattopadhyay M.D.", "title": "Senior VP & Head of Translational Medicine", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ray  Lockard M.B.A.", "title": "Senior Vice President & Head of Quality", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.0, "open": 1.0, "dayLow": 0.9902, "dayHigh": 1.04, "regularMarketPreviousClose": 1.0, "regularMarketOpen": 1.0, "regularMarketDayLow": 0.9902, "regularMarketDayHigh": 1.04, "payoutRatio": 0.0, "beta": 1.03, "forwardPE": -1.0174563, "volume": 344994, "regularMarketVolume": 344994, "averageVolume": 812485, "averageVolume10days": 638400, "averageDailyVolume10Day": 638400, "bid": 0.6813, "ask": 1.22, "bidSize": 2, "askSize": 2, "marketCap": 57882952, "fiftyTwoWeekLow": 0.882, "fiftyTwoWeekHigh": 3.133, "allTimeHigh": 14.71, "allTimeLow": 0.882, "priceToSalesTrailing12Months": 6.872011, "fiftyDayAverage": 1.21044, "twoHundredDayAverage": 1.55111, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -30948048, "profitMargins": 0.0, "floatShares": 44336072, "sharesOutstanding": 52471405, "sharesShort": 2539912, "sharesShortPriorMonth": 1949768, "sharesShortPreviousMonthDate": 1763078400, "dateShortInterest": 1765756800, "sharesPercentSharesOut": 0.0448, "heldPercentInsiders": 0.00228, "heldPercentInstitutions": 0.73334, "shortRatio": 3.11, "shortPercentOfFloat": 0.0544, "impliedSharesOutstanding": 56747993, "bookValue": 2.538, "priceToBook": 0.40189123, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -142598000, "trailingEps": -1.12, "forwardEps": -1.0025, "enterpriseToRevenue": -3.674, "enterpriseToEbitda": 0.212, "52WeekChange": -0.6577181, "SandP52WeekChange": 0.14778805, "quoteType": "EQUITY", "currentPrice": 1.02, "targetHighPrice": 7.0, "targetLowPrice": 5.0, "targetMeanPrice": 6.0, "targetMedianPrice": 6.0, "recommendationKey": "none", "numberOfAnalystOpinions": 4, "totalCash": 184452992, "totalCashPerShare": 3.25, "ebitda": -145812992, "totalDebt": 95622000, "quickRatio": 6.315, "currentRatio": 6.442, "totalRevenue": 8423000, "debtToEquity": 66.394, "revenuePerShare": 0.148, "returnOnAssets": -0.30452, "returnOnEquity": -0.76438004, "grossProfits": -12538000, "freeCashflow": -87761752, "operatingCashflow": -130729000, "revenueGrowth": 1.394, "grossMargins": -1.48854, "ebitdaMargins": 0.0, "operatingMargins": -14.755871, "financialCurrency": "USD", "symbol": "TCRX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1626442200000, "postMarketChangePercent": 0.019611098, "postMarketPrice": 1.0202, "postMarketChange": 0.00020003319, "regularMarketChange": 0.02, "regularMarketDayRange": "0.9902 - 1.04", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 812485, "fiftyTwoWeekLowChange": 0.13799995, "fiftyTwoWeekLowChangePercent": 0.15646252, "fiftyTwoWeekRange": "0.882 - 3.133", "fiftyTwoWeekHighChange": -2.113, "fiftyTwoWeekHighChangePercent": -0.67443347, "fiftyTwoWeekChangePercent": -65.77181, "earningsTimestampStart": 1762954200, "earningsTimestampEnd": 1762954200, "isEarningsDateEstimate": true, "corporateActions": [], "postMarketTime": 1767397055, "regularMarketTime": 1767387601, "shortName": "TScan Therapeutics, Inc.", "longName": "TScan Therapeutics, Inc.", "regularMarketChangePercent": 2.0, "regularMarketPrice": 1.02, "exchange": "NGM", "messageBoardId": "finmb_583057578", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "epsTrailingTwelveMonths": -1.12, "epsForward": -1.0025, "epsCurrentYear": -1.244, "priceEpsCurrentYear": -0.8199357, "fiftyDayAverageChange": -0.19044006, "fiftyDayAverageChangePercent": -0.15733126, "twoHundredDayAverageChange": -0.53111005, "twoHundredDayAverageChangePercent": -0.34240642, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-07-16", "cryptoTradeable": false, "displayName": "TScan Therapeutics", "trailingPegRatio": null, "__fetch_time": "2026-01-03"}]